Skip to main content
Terug
Watch Compare

CHAMPIONS ONCOLOGY, INC.

Datakwaliteit: 100%
CSBR
Nasdaq Manufacturing Chemicals
€ 5,85
▼ € 0,18 (-2,99%)
Marktkapitalisatie: 81,24 M
Prijs
€ 5,85
Marktkapitalisatie
81,24 M
Dagbereik
€ 5,70 — € 5,86
52-Weeksbereik
€ 5,50 — € 9,63
Volume
9.002
Openen € 5,86
50D / 200D Gem.
€ 6,18
5,38% below
50D / 200D Gem.
€ 6,73
13,03% below

Quick Summary

Belangrijkste Punten

Revenue grew 8,53% annually over 5 years — modest growth
Generating 3,82 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5,01%
Capital efficient — spends only 1,00% of revenue on capex

Groei

Revenue Growth (5Y)
8,53%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)13,54%
Earnings (1Y)N/A
FCF Growth (3Y)152,21%

Kwaliteit

Return on Equity
-55,44%
Onder sectorgemiddelde (-53,41%)
ROIC-26,26%
Net Margin-4,04%
Op. Margin-4,53%

Veiligheid

Debt / Equity
N/A
Current Ratio0,98
Interest CoverageN/A

Waardering

PE (TTM)
-34,67
Onder sectorgemiddelde (-1,48)
P/B Ratio18,97
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -34,7 -1,5
P/B 19,0 1,6
ROE % -55,4 -53,4
Net Margin % -4,0 -41,5
Rev Growth 5Y % 8,5 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 13,54% Revenue Growth (3Y) 2,81%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 8,53% Earnings Growth (5Y) 89,83%
Profitability
Revenue (TTM) 57,95 M Net Income (TTM) -2,34 M
ROE -55,44% ROA -8,00%
Gross Margin N/A Operating Margin -4,53%
Net Margin -4,04% Free Cash Flow (TTM) 3,82 M
ROIC -26,26% FCF Growth (3Y) 152,21%
Safety
Debt / Equity N/A Current Ratio 0,98
Interest Coverage N/A Asset Turnover 1,98
Working Capital -492.000 Tangible Book Value 3,95 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -34,67 Forward P/E N/A
P/B Ratio 18,97 P/S Ratio 1,40
PEG Ratio -0,39 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 4,70%
Market Cap 81,24 M Enterprise Value 74,11 M
Per Share
EPS (Diluted TTM) -0,17 Revenue / Share 4,17
FCF / Share 0,27 OCF / Share 0,32
EPS CAGR (1Y) N/A EPS CAGR (5Y) 101,54%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,00% FCF Conversion -162,87%
SBC-Adj. FCF 2,68 M Growth Momentum 5,01

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 56,94 M 50,16 M 53,87 M 49,11 M 41,04 M
Net Income 4,70 M -7,28 M -5,34 M 548.000,0 362.000,0
EPS (Diluted) 0,33 -0,54 -0,39 0,04 0,02
Gross Profit — — — — —
Operating Income 4,55 M -7,36 M -5,26 M 607.000,0 366.000,0
EBITDA — — — — —
R&D Expenses 6,83 M 9,54 M 11,55 M 9,37 M 7,20 M
SG&A Expenses — — — — —
D&A 1,60 M 1,70 M 2,10 M 1,50 M 1,20 M
Interest Expense — — — — —
Income Tax -75.000,0 -32.000,0 68.000,0 35.000,0 75.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 32,34 M 26,13 M 34,31 M 35,38 M 27,59 M
Total Liabilities 28,57 M 28,04 M 29,68 M 26,28 M 20,16 M
Shareholders' Equity 3,77 M -1,90 M 4,64 M 9,10 M 7,43 M
Total Debt — — — — —
Cash & Equivalents — — — — —
Current Assets 22,37 M 13,64 M 19,46 M 19,66 M 12,63 M
Current Liabilities 23,85 M 21,54 M 21,73 M 17,48 M 11,20 M